Document is current
Any future updates will be listed below
-
Authors
Pilcher, William
Thomas, Beena E.
Bhasin, Swati S.
Jayasinghe, Reyka G. https://orcid.org/0000-0003-2368-4890
Yao, Lijun
Gonzalez-Kozlova, Edgar https://orcid.org/0000-0002-6948-0626
Dasari, Surendra
Kim-Schulze, Seunghee
Rahman, Adeeb
Patton, Jonathan https://orcid.org/0000-0002-1198-6341
Fiala, Mark
Cheloni, Giulia
Kourelis, Taxiarchis
Dhodapkar, Madhav V. https://orcid.org/0000-0002-8249-5988
Vij, Ravi
Mehr, Shaadi
Hamilton, Mark
Cho, Hearn Jay
Auclair, Daniel
Avigan, David E.
Kumar, Shaji K.
Gnjatic, Sacha https://orcid.org/0000-0001-5643-9520
Ding, Li
Bhasin, Manoj
- License Information
-
More Information
Article History
Received: 29 March 2022
Accepted: 18 November 2022
First Online: 26 January 2023
Competing interests
: This study was supported by the Multiple Myeloma Research Foundation (MMRF). M.H., S.M., H.J.C., and D.A. are employed by the MMRF, but they did not have a role in the interpretation of the results. S.G. is additionally supported by grants U24 CA224319 and U01 DK124165. The Mount Sinai Human Immune Monitoring Center is supported in part by Cancer Center grant P01 CA196521. S.G. reports consultancy and/or advisory roles for Merck, and OncoMed and research funding from Bristol-Myers Squibb, Genentech, Janssen R&D, Pfizer, Celgene, Takeda, and Regeneron. Other authors declare no competing interests.
